PolyPeptide Group AG (LON:0AAJ)
London
· Delayed Price · Currency is GBP · Price in CHF 16.06
0.00 (0.00%)
At close: Apr 17, 2025
PolyPeptide Group AG Revenue
In the year 2024, PolyPeptide Group AG had annual revenue of 336.79M EUR with 5.13% growth. PolyPeptide Group AG had revenue of 201.75M in the half year ending December 31, 2024, with 36.94% growth.
Revenue
336.79M EUR
Revenue Growth
+5.13%
P/S Ratio
1.88
Revenue / Employee
247.28K EUR
Employees
1,362
Market Cap
523.12M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |